These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34894517)

  • 1. Curcumin, novel application in reversing myocardial fibrosis in the treatment for atrial fibrillation from the perspective of transcriptomics in rat model.
    Yue H; Zhao X; Liang W; Qin X; Bian L; He K; Wu Z
    Biomed Pharmacother; 2022 Feb; 146():112522. PubMed ID: 34894517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colchicine: Emerging therapeutic effects on atrial fibrillation by alleviating myocardial fibrosis in a rat model.
    Yue H; Liang W; Zhan Y; Zhang Z; Qin X; Bian L; He K; Wu Z
    Biomed Pharmacother; 2022 Oct; 154():113573. PubMed ID: 35987161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-receptor blocker losartan alleviates atrial fibrillation in rats by downregulating frizzled 8 and inhibiting the activation of WNT-5A pathway.
    Feng R; Wan J; He Y; Gong H; Xu Z; Feng J
    Clin Exp Pharmacol Physiol; 2023 Jan; 50(1):19-27. PubMed ID: 36047789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-17A contributes to the development of post-operative atrial fibrillation by regulating inflammation and fibrosis in rats with sterile pericarditis.
    Fu XX; Zhao N; Dong Q; Du LL; Chen XJ; Wu QF; Cheng X; Du YM; Liao YH
    Int J Mol Med; 2015 Jul; 36(1):83-92. PubMed ID: 25955429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigallocatechin-3-Gallate Inhibits Atrial Fibrosis and Reduces the Occurrence and Maintenance of Atrial Fibrillation and its Possible Mechanisms.
    Li T; Tong Q; Wang Z; Yang Z; Sun Y; Cai J; Xu Q; Lu Y; Liu X; Lin K; Qian Y
    Cardiovasc Drugs Ther; 2024 Oct; 38(5):895-916. PubMed ID: 37000367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of MG53 in the regulation of transforming-growth-factor-β1-induced atrial fibrosis and vulnerability to atrial fibrillation.
    Guo J; Jia F; Jiang Y; Li Q; Yang Y; Xiao M; Xiao H
    Exp Cell Res; 2018 Jan; 362(2):436-443. PubMed ID: 29233682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative transcriptome analysis to elucidate the therapeutic mechanism of colchicine against atrial fibrillation.
    Yue H; Liang W; Gu J; Zhao X; Zhang T; Qin X; Zhu G; Wu Z
    Biomed Pharmacother; 2019 Nov; 119():109422. PubMed ID: 31514070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MIAT/miR-133a-3p axis regulates atrial fibrillation and atrial fibrillation-induced myocardial fibrosis.
    Yao L; Zhou B; You L; Hu H; Xie R
    Mol Biol Rep; 2020 Apr; 47(4):2605-2617. PubMed ID: 32130618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTRP9 Ameliorates Atrial Inflammation, Fibrosis, and Vulnerability to Atrial Fibrillation in Post-Myocardial Infarction Rats.
    Liu M; Li W; Wang H; Yin L; Ye B; Tang Y; Huang C
    J Am Heart Assoc; 2019 Nov; 8(21):e013133. PubMed ID: 31623508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colchicine prevents atrial fibrillation promotion by inhibiting IL-1β-induced IL-6 release and atrial fibrosis in the rat sterile pericarditis model.
    Wu Q; Liu H; Liao J; Zhao N; Tse G; Han B; Chen L; Huang Z; Du Y
    Biomed Pharmacother; 2020 Sep; 129():110384. PubMed ID: 32554248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Susceptibility to Atrial Fibrillation Secondary to Atrial Fibrosis in Transgenic Goats Expressing Transforming Growth Factor-β1.
    Polejaeva IA; Ranjan R; Davies CJ; Regouski M; Hall J; Olsen AL; Meng Q; Rutigliano HM; Dosdall DJ; Angel NA; Sachse FB; Seidel T; Thomas AJ; Stott R; Panter KE; Lee PM; Van Wettere AJ; Stevens JR; Wang Z; MacLeod RS; Marrouche NF; White KL
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1220-1229. PubMed ID: 27447370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-β1/Smad2/3 pathway.
    Ge Z; Chen Y; Wang B; Zhang X; Yan Y; Zhou L; Zhang Y; Xie Y
    J Mol Cell Cardiol; 2020 Feb; 139():164-175. PubMed ID: 31958465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvianolate reduces atrial fibrillation through suppressing atrial interstitial fibrosis by inhibiting TGF-β1/Smad2/3 and TXNIP/NLRP3 inflammasome signaling pathways in post-MI rats.
    Qiu H; Liu W; Lan T; Pan W; Chen X; Wu H; Xu D
    Phytomedicine; 2018 Dec; 51():255-265. PubMed ID: 30466624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Sox9 on TGF-β1-mediated atrial fibrosis.
    Wang H; Chen Y; Zhao S; Wang X; Lu K; Xiao H
    Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1450-1458. PubMed ID: 34596216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR‑101a‑3p overexpression prevents acetylcholine‑CaCl
    Zhu J; Zhu N; Xu J
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34435649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-β-mediated CD44/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation.
    Chang SH; Yeh YH; Lee JL; Hsu YJ; Kuo CT; Chen WJ
    Basic Res Cardiol; 2017 Sep; 112(5):58. PubMed ID: 28871329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of miR-27b-3p Targeting Wnt3a Regulates the Signaling Pathway of Wnt/
    Lv X; Li J; Hu Y; Wang S; Yang C; Li C; Zhong G
    Oxid Med Cell Longev; 2019; 2019():5703764. PubMed ID: 31178968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation.
    Zhao F; Zhang S; Shao Y; Wu Y; Qin J; Chen Y; Chen L; Gu H; Wang X; Huang C; Zhang W
    Int J Cardiol; 2013 Oct; 168(3):2177-85. PubMed ID: 23465222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2 Ameliorates Atrial Fibrosis During Antithrombotic Therapy for Atrial Fibrillation by Modulating CYP2C9 Activity.
    Wu L; Li Z; Xu L; Fan Y; Mao D; Sun H; Zhuang W
    J Cardiovasc Pharmacol; 2024 Oct; 84(4):440-450. PubMed ID: 39150397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased α-Actinin-2 Expression in the Atrial Myocardium of Patients with Atrial Fibrillation Related to Rheumatic Heart Disease.
    Zhang L; Zhang N; Tang X; Liu F; Luo S; Xiao H
    Cardiology; 2016; 135(3):151-159. PubMed ID: 27344599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.